Acceder

Publicaciones - Control molecular de la proliferación y diferenciación

Cargando...
Sanchez-Beltran J, Soler Diaz J, Herraiz C, Olivares C, Cerdido S, Cerezuela-Fuentes P, Garcia-Borron JC, Jimenez-Cervantes C. An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival. Int J Mol Sci. 2025 Feb 18;26(4):1739. doi: 10.3390/ijms26041739. PubMed PMID: 40004203; PubMed Central PMCID: PMC11855888.
AÑO: 2025; IF: 4.9
Stefanaki I, D'Ecclesiis O, Vignati S, Gaeta A, Kypreou K, Caini S, Gandini S, Nagore E, Sera F, Botta F, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Puig S, Gruis NA, Landi MT, Fargnoli MC, Stratigos A, Guida G, Ghiorzo P, Menin C, Garcia-Borron JC, Little J, Nan H, Raimondi S; M-SKIP study group. Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP project. J Eur Acad Dermatol Venereol. 2024 Oct 19:10.1111/jdv.20380. doi: 10.1111/jdv.20380. Online ahead of print. No abstract available. PubMed PMID: 39425518; PubMed Central PMCID: PMC12008258.
AÑO: 2024; IF: 8.4
Boyano M.D., Asumendi A., Garcia-Borrón J.C., Montoliu L., Alonso S. IPCC2023: Looking for translational opportunities by persevering in basic pigment cell research. Pigment Cell and Melanoma Research. September 2024. 37:546-554. 10.1111/pcmr.13148
AÑO: 2024; IF: 3.9
Cerdido S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, Castejon-Grinan M, Munoz C, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C, Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Lett. 2024 Jan 28;581:216484. doi: 10.1016/j.canlet.2023.216484. Epub 2023 Nov 25. PubMed PMID: 38008393.
AÑO: 2024; IF: 9.1
Castejón-Griñán M., Cerdido S., Sánchez-Beltrán J., Lambertos A., Abrisqueta M., Herraiz C., Jiménez-Cervantes C., García-Borrón J.C. Melanoma-associated melanocortin 1 receptor variants confer redox signaling-dependent protection against oxidative DNA damage. Redox Biology. June 2024. 72. 10.1016/j.redox.2024.103135
AÑO: 2024; IF: 10.7
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Control molecular de la proliferación y diferenciación